A study in healthy subjects to investigate Pharmacokinetics of AZD5423 when administered in different ways

Study identifier:D2340C00012

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Single Centre, Open, Partly Randomised, Crossover Study in Healthy Subjects to Evaluate AZD5423 Absolute Pulmonary Bioavailability when Administered Inhaled via a New Dry Powder Inhaler, Turbuhaler, Spira nebulizer and I-neb AAD system

Medical condition

Bioavailability and AUC

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD5423

Sex

Male

Actual Enrollment

18

Study type

Interventional

Age

18 Years - 45 Years

Date

Study Start Date: 01 Aug 2012
Primary Completion Date: 01 Dec 2012
Study Completion Date: 01 Dec 2012

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Jan 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria